114 related articles for article (PubMed ID: 16782968)
1. Interdomain communication in DNA topoisomerase II. DNA binding and enzyme activation.
Mueller-Planitz F; Herschlag D
J Biol Chem; 2006 Aug; 281(33):23395-404. PubMed ID: 16782968
[TBL] [Abstract][Full Text] [Related]
2. Communication between the ATPase and cleavage/religation domains of human topoisomerase IIalpha.
Bjergbaek L; Kingma P; Nielsen IS; Wang Y; Westergaard O; Osheroff N; Andersen AH
J Biol Chem; 2000 Apr; 275(17):13041-8. PubMed ID: 10777608
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of the DNA-dependent ATPase activity of human DNA topoisomerase IIbeta: mutation of Ser165 in the ATPase domain reduces the ATPase activity and abolishes the in vivo complementation ability.
West KL; Turnbull RM; Willmore E; Lakey JH; Austin CA
Nucleic Acids Res; 2002 Dec; 30(24):5416-24. PubMed ID: 12490710
[TBL] [Abstract][Full Text] [Related]
4. Hindering the strand passage reaction of human topoisomerase IIalpha without disturbing DNA cleavage, ATP hydrolysis, or the operation of the N-terminal clamp.
Oestergaard VH; Giangiacomo L; Bjergbaek L; Knudsen BR; Andersen AH
J Biol Chem; 2004 Jul; 279(27):28093-9. PubMed ID: 15123700
[TBL] [Abstract][Full Text] [Related]
5. On the coupling between ATP usage and DNA transport by yeast DNA topoisomerase II.
Lindsley JE; Wang JC
J Biol Chem; 1993 Apr; 268(11):8096-104. PubMed ID: 8385137
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the DNA-binding domain and identification of the active site residue in the 'Gyr A' half of Leishmania donovani topoisomerase II.
Sengupta T; Mukherjee M; Das R; Das A; Majumder HK
Nucleic Acids Res; 2005; 33(8):2364-73. PubMed ID: 15860773
[TBL] [Abstract][Full Text] [Related]
7. Mutagenesis of E477 or K505 in the B' domain of human topoisomerase II beta increases the requirement for magnesium ions during strand passage.
West KL; Meczes EL; Thorn R; Turnbull RM; Marshall R; Austin CA
Biochemistry; 2000 Feb; 39(6):1223-33. PubMed ID: 10684600
[TBL] [Abstract][Full Text] [Related]
8. A human topoisomerase II alpha heterodimer with only one ATP binding site can go through successive catalytic cycles.
Skouboe C; Bjergbaek L; Oestergaard VH; Larsen MK; Knudsen BR; Andersen AH
J Biol Chem; 2003 Feb; 278(8):5768-74. PubMed ID: 12480934
[TBL] [Abstract][Full Text] [Related]
9. Kinetic and thermodynamic analysis of mutant type II DNA topoisomerases that cannot covalently cleave DNA.
Morris SK; Harkins TT; Tennyson RB; Lindsley JE
J Biol Chem; 1999 Feb; 274(6):3446-52. PubMed ID: 9920889
[TBL] [Abstract][Full Text] [Related]
10. DNA topoisomerase II selects DNA cleavage sites based on reactivity rather than binding affinity.
Mueller-Planitz F; Herschlag D
Nucleic Acids Res; 2007; 35(11):3764-73. PubMed ID: 17517767
[TBL] [Abstract][Full Text] [Related]
11. Mutation of cysteine residue 455 to alanine in human topoisomerase IIalpha confers hypersensitivity to quinones: enhancing DNA scission by closing the N-terminal protein gate.
Bender RP; Osheroff N
Chem Res Toxicol; 2007 Jun; 20(6):975-81. PubMed ID: 17516663
[TBL] [Abstract][Full Text] [Related]
12. Selection of DNA Cleavage Sites by Topoisomerase II Results from Enzyme-Induced Flexibility of DNA.
Jang Y; Son H; Lee SW; Hwang W; Jung SR; Byl JAW; Osheroff N; Lee S
Cell Chem Biol; 2019 Apr; 26(4):502-511.e3. PubMed ID: 30713098
[TBL] [Abstract][Full Text] [Related]
13. Probing the interaction of the cytotoxic bisdioxopiperazine ICRF-193 with the closed enzyme clamp of human topoisomerase IIalpha.
Patel S; Jazrawi E; Creighton AM; Austin CA; Fisher LM
Mol Pharmacol; 2000 Sep; 58(3):560-8. PubMed ID: 10953049
[TBL] [Abstract][Full Text] [Related]
14. Catalysis of ATP hydrolysis by two NH(2)-terminal fragments of yeast DNA topoisomerase II.
Olland S; Wang JC
J Biol Chem; 1999 Jul; 274(31):21688-94. PubMed ID: 10419479
[TBL] [Abstract][Full Text] [Related]
15. Coupling between ATP binding and DNA cleavage by DNA topoisomerase II: A unifying kinetic and structural mechanism.
Mueller-Planitz F; Herschlag D
J Biol Chem; 2008 Jun; 283(25):17463-76. PubMed ID: 18403371
[TBL] [Abstract][Full Text] [Related]
16. The ATPase reaction cycle of yeast DNA topoisomerase II. Slow rates of ATP resynthesis and P(i) release.
Baird CL; Gordon MS; Andrenyak DM; Marecek JF; Lindsley JE
J Biol Chem; 2001 Jul; 276(30):27893-8. PubMed ID: 11353771
[TBL] [Abstract][Full Text] [Related]
17. Stability of the topoisomerase II closed clamp conformation may influence DNA-stimulated ATP hydrolysis.
Vaughn J; Huang S; Wessel I; Sorensen TK; Hsieh T; Jensen LH; Jensen PB; Sehested M; Nitiss JL
J Biol Chem; 2005 Mar; 280(12):11920-9. PubMed ID: 15647268
[TBL] [Abstract][Full Text] [Related]
18. Cooperative kinetics of both Hsp104 ATPase domains and interdomain communication revealed by AAA sensor-1 mutants.
Hattendorf DA; Lindquist SL
EMBO J; 2002 Jan; 21(1-2):12-21. PubMed ID: 11782421
[TBL] [Abstract][Full Text] [Related]
19. Effects of topoisomerase II-targeted drugs on enzyme-mediated DNA cleavage and ATP hydrolysis: evidence for distinct drug interaction domains on topoisomerase II.
Robinson MJ; Corbett AH; Osheroff N
Biochemistry; 1993 Apr; 32(14):3638-43. PubMed ID: 8385484
[TBL] [Abstract][Full Text] [Related]
20. gyrB-225, a mutation of DNA gyrase that compensates for topoisomerase I deficiency: investigation of its low activity and quinolone hypersensitivity.
Heddle JG; Lu T; Zhao X; Drlica K; Maxwell A
J Mol Biol; 2001 Jun; 309(5):1219-31. PubMed ID: 11399091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
